vs
DBV Technologies S.A.（DBVT）与VerifyMe, Inc.（VRME）财务数据对比。点击上方公司名可切换其他公司
VerifyMe, Inc.的季度营收约是DBV Technologies S.A.的1.8倍（$5.0M vs $2.8M），VerifyMe, Inc.净利率更高（-66.7% vs -1195.5%，领先1128.9%），DBV Technologies S.A.同比增速更快（158.8% vs -7.4%），过去两年DBV Technologies S.A.的营收复合增速更高（12.4% vs -5.2%）
DBV Technologies是一家总部位于法国巴涅的公开上市生物制药企业，核心研发成果为Viaskin给药技术，可在不进入血液循环的前提下，让过敏原或抗原作用于完整皮肤。其花生过敏疗法Viaskin Peanut的临床开发，已获得美国食品药品监督管理局授予快速通道资格。
VerifyMe, Inc.是一家专注于身份核验、防伪溯源及品牌保护服务的科技企业，为消费品、制药、零售等行业客户提供安全认证工具、全链路溯源系统与用户互动解决方案，业务覆盖北美及多个海外市场。
DBVT vs VRME — 直观对比
营收规模更大
VRME
是对方的1.8倍
$2.8M
营收增速更快
DBVT
高出166.2%
-7.4%
净利率更高
VRME
高出1128.9%
-1195.5%
两年增速更快
DBVT
近两年复合增速
-5.2%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $5.0M |
| 净利润 | $-33.2M | $-3.4M |
| 毛利率 | — | 41.2% |
| 营业利润率 | -1235.7% | -68.2% |
| 净利率 | -1195.5% | -66.7% |
| 营收同比 | 158.8% | -7.4% |
| 净利润同比 | -8.9% | -38.4% |
| 每股收益（稀释后） | $-0.24 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DBVTVRME
| Q3 25 | $2.8M | $5.0M | ||
| Q2 25 | $1.5M | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q3 24 | — | $5.4M | ||
| Q2 24 | $1.2M | $5.4M | ||
| Q1 24 | $1.4M | $5.8M | ||
| Q4 23 | $8.9M | $8.7M | ||
| Q3 23 | $2.4M | $5.6M |
净利润DBVTVRME
| Q3 25 | $-33.2M | $-3.4M | ||
| Q2 25 | $-41.9M | $-291.0K | ||
| Q1 25 | — | $-571.0K | ||
| Q3 24 | — | $-2.4M | ||
| Q2 24 | $-33.1M | $-346.0K | ||
| Q1 24 | $-27.3M | $-553.0K | ||
| Q4 23 | $134.3M | $2.0K | ||
| Q3 23 | $-16.7M | $-930.0K |
毛利率DBVTVRME
| Q3 25 | — | 41.2% | ||
| Q2 25 | — | 35.2% | ||
| Q1 25 | — | 33.4% | ||
| Q3 24 | — | 34.9% | ||
| Q2 24 | — | 39.1% | ||
| Q1 24 | — | 39.2% | ||
| Q4 23 | — | 33.0% | ||
| Q3 23 | — | 36.5% |
营业利润率DBVTVRME
| Q3 25 | -1235.7% | -68.2% | ||
| Q2 25 | -2806.2% | -7.1% | ||
| Q1 25 | — | -13.3% | ||
| Q3 24 | — | -52.8% | ||
| Q2 24 | -2914.9% | -10.0% | ||
| Q1 24 | -2029.7% | -11.2% | ||
| Q4 23 | -134.3% | 0.8% | ||
| Q3 23 | -770.2% | -15.3% |
净利率DBVTVRME
| Q3 25 | -1195.5% | -66.7% | ||
| Q2 25 | -2858.4% | -6.4% | ||
| Q1 25 | — | -12.8% | ||
| Q3 24 | — | -44.6% | ||
| Q2 24 | -2852.4% | -6.5% | ||
| Q1 24 | -1943.5% | -9.6% | ||
| Q4 23 | 1512.8% | 0.0% | ||
| Q3 23 | -705.6% | -16.6% |
每股收益（稀释后）DBVTVRME
| Q3 25 | $-0.24 | $-0.26 | ||
| Q2 25 | $-0.31 | $-0.02 | ||
| Q1 25 | — | $-0.05 | ||
| Q3 24 | — | $-0.23 | ||
| Q2 24 | $-0.34 | $-0.03 | ||
| Q1 24 | $-0.28 | $-0.05 | ||
| Q4 23 | $-0.11 | $0.00 | ||
| Q3 23 | $-0.17 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $52.9M | $11.1M |
| 总资产 | $110.5M | $13.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DBVTVRME
| Q3 25 | $69.8M | — | ||
| Q2 25 | $103.2M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | $66.2M | $2.9M | ||
| Q1 24 | $101.5M | $2.8M | ||
| Q4 23 | $141.4M | $3.0M | ||
| Q3 23 | $149.1M | $2.9M |
总债务DBVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $500.0K | ||
| Q2 24 | — | $600.0K | ||
| Q1 24 | — | $800.0K | ||
| Q4 23 | — | $875.0K | ||
| Q3 23 | — | $1.0M |
股东权益DBVTVRME
| Q3 25 | $52.9M | $11.1M | ||
| Q2 25 | $86.2M | $14.4M | ||
| Q1 25 | — | $14.6M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | $79.1M | $12.3M | ||
| Q1 24 | $111.7M | $12.4M | ||
| Q4 23 | $140.2M | — | ||
| Q3 23 | $144.0M | $11.9M |
总资产DBVTVRME
| Q3 25 | $110.5M | $13.3M | ||
| Q2 25 | $143.4M | $17.2M | ||
| Q1 25 | — | $17.1M | ||
| Q3 24 | — | $14.8M | ||
| Q2 24 | $114.2M | $17.5M | ||
| Q1 24 | $145.9M | $17.9M | ||
| Q4 23 | $183.0M | $20.7M | ||
| Q3 23 | $189.8M | $18.8M |
负债/权益比DBVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.06× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.4M | $243.0K |
| 自由现金流经营现金流 - 资本支出 | $-32.6M | — |
| 自由现金流率自由现金流/营收 | -1173.5% | — |
| 资本支出强度资本支出/营收 | 4.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-138.3M | — |
8季度趋势，按日历期对齐
经营现金流DBVTVRME
| Q3 25 | $-32.4M | $243.0K | ||
| Q2 25 | $-33.9M | $710.0K | ||
| Q1 25 | — | $-404.0K | ||
| Q3 24 | — | $-10.0K | ||
| Q2 24 | $-35.1M | $372.0K | ||
| Q1 24 | $-34.7M | $-60.0K | ||
| Q4 23 | $-13.7M | $843.0K | ||
| Q3 23 | $-19.6M | $-136.0K |
自由现金流DBVTVRME
| Q3 25 | $-32.6M | — | ||
| Q2 25 | $-33.9M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $-12.0K | ||
| Q2 24 | $-35.8M | $369.0K | ||
| Q1 24 | $-36.0M | $-62.0K | ||
| Q4 23 | $-14.0M | $840.0K | ||
| Q3 23 | $-19.6M | — |
自由现金流率DBVTVRME
| Q3 25 | -1173.5% | — | ||
| Q2 25 | -2316.5% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | -0.2% | ||
| Q2 24 | -3084.0% | 6.9% | ||
| Q1 24 | -2560.6% | -1.1% | ||
| Q4 23 | -158.2% | 9.6% | ||
| Q3 23 | -827.3% | — |
资本支出强度DBVTVRME
| Q3 25 | 4.2% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 63.0% | 0.1% | ||
| Q1 24 | 94.9% | 0.0% | ||
| Q4 23 | 4.0% | 0.0% | ||
| Q3 23 | 2.1% | 0.0% |
现金转化率DBVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | -0.10× | 421.50× | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DBVT
暂无分部数据
VRME
| Proactive Services | $4.2M | 83% |
| Other | $869.0K | 17% |
